Race to save kidneys in ICU patients on Last-Resort antibiotic
NCT ID NCT06650384
Summary
This study aimed to see if two antioxidant supplements, N-Acetylcysteine or Alpha-Lipoic Acid, could prevent or reduce kidney damage in critically ill patients who needed the powerful antibiotic colistin. Colistin is a last-resort treatment for dangerous, drug-resistant infections but can harm the kidneys. Researchers compared 180 patients receiving the antibiotic alone, with N-Acetylcysteine, or with Alpha-Lipoic Acid to see which group had less kidney injury.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEPHROTOXICITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Critical Care Medicine Department,Cairo University Hospitals
Cairo, Egypt
Conditions
Explore the condition pages connected to this study.